160 related articles for article (PubMed ID: 18572035)
1. Serum cystatin C and increased coronary heart disease prevalence in US adults without chronic kidney disease.
Muntner P; Mann D; Winston J; Bansilal S; Farkouh ME
Am J Cardiol; 2008 Jul; 102(1):54-7. PubMed ID: 18572035
[TBL] [Abstract][Full Text] [Related]
2. Cystatin C and the risk of death and cardiovascular events among elderly persons.
Shlipak MG; Sarnak MJ; Katz R; Fried LF; Seliger SL; Newman AB; Siscovick DS; Stehman-Breen C
N Engl J Med; 2005 May; 352(20):2049-60. PubMed ID: 15901858
[TBL] [Abstract][Full Text] [Related]
3. Does HAART improve renal function? An association between serum cystatin C concentration, HIV viral load and HAART duration.
Jaroszewicz J; Wiercinska-Drapalo A; Lapinski TW; Prokopowicz D; Rogalska M; Parfieniuk A
Antivir Ther; 2006; 11(5):641-5. PubMed ID: 16964834
[TBL] [Abstract][Full Text] [Related]
4. Impact of elevated cystatin C level on cardiovascular disease risk in predominantly high cardiovascular risk populations: a meta-analysis.
Lee M; Saver JL; Huang WH; Chow J; Chang KH; Ovbiagele B
Circ Cardiovasc Qual Outcomes; 2010 Nov; 3(6):675-83. PubMed ID: 20923994
[TBL] [Abstract][Full Text] [Related]
5. Association of analgesic use with prevalence of albuminuria and reduced GFR in US adults.
Agodoa LY; Francis ME; Eggers PW
Am J Kidney Dis; 2008 Apr; 51(4):573-83. PubMed ID: 18371533
[TBL] [Abstract][Full Text] [Related]
6. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in non-diabetic patients with stage 2-4 chronic kidney disease.
Malyszko J; Bachorzewska-Gajewska H; Sitniewska E; Malyszko JS; Poniatowski B; Dobrzycki S
Ren Fail; 2008; 30(6):625-8. PubMed ID: 18661413
[TBL] [Abstract][Full Text] [Related]
7. Cystatin C and cardiovascular mortality in patients with coronary artery disease and normal or mildly reduced kidney function: results from the AtheroGene study.
Keller T; Messow CM; Lubos E; Nicaud V; Wild PS; Rupprecht HJ; Bickel C; Tzikas S; Peetz D; Lackner KJ; Tiret L; Münzel TF; Blankenberg S; Schnabel RB
Eur Heart J; 2009 Feb; 30(3):314-20. PubMed ID: 19153178
[TBL] [Abstract][Full Text] [Related]
8. Chronic kidney disease and functional limitation in older people: health, aging and body composition study.
Fried LF; Lee JS; Shlipak M; Chertow GM; Green C; Ding J; Harris T; Newman AB
J Am Geriatr Soc; 2006 May; 54(5):750-6. PubMed ID: 16696739
[TBL] [Abstract][Full Text] [Related]
9. GFR estimated from cystatin C versus creatinine in children born small for gestational age.
Franco MC; Nishida SK; Sesso R
Am J Kidney Dis; 2008 Jun; 51(6):925-32. PubMed ID: 18455848
[TBL] [Abstract][Full Text] [Related]
10. Chronic kidney disease, prevalence of premature cardiovascular disease, and relationship to short-term mortality.
McCullough PA; Li S; Jurkovitz CT; Stevens L; Collins AJ; Chen SC; Norris KC; McFarlane S; Johnson B; Shlipak MG; Obialo CI; Brown WW; Vassalotti J; Whaley-Connell AT; Brenner RM; Bakris GL;
Am Heart J; 2008 Aug; 156(2):277-83. PubMed ID: 18657657
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of cystatin C and serum creatinine in the estimative of glomerular filtration rate in children.
Cordeiro VF; Pinheiro DC; Silva GB; Lima JW; Mota RM; Libório AB; Daher EF
Clin Chim Acta; 2008 May; 391(1-2):46-50. PubMed ID: 18298952
[TBL] [Abstract][Full Text] [Related]
12. Association between markers of renal function and C-reactive protein level in the elderly: confounding by functional status.
Wasén E; Isoaho R; Vahlberg T; Kivelä SL; Irjala K
Scand J Clin Lab Invest; 2008; 68(6):484-91. PubMed ID: 18609082
[TBL] [Abstract][Full Text] [Related]
13. Relationship between hepatitis C and chronic kidney disease: results from the Third National Health and Nutrition Examination Survey.
Tsui JI; Vittinghoff E; Shlipak MG; O'Hare AM
J Am Soc Nephrol; 2006 Apr; 17(4):1168-74. PubMed ID: 16524948
[TBL] [Abstract][Full Text] [Related]
14. Association of cystatin C with poor exercise capacity and heart rate recovery: data from the heart and soul study.
McManus D; Shlipak M; Ix JH; Ali S; Whooley MA
Am J Kidney Dis; 2007 Mar; 49(3):365-72. PubMed ID: 17336697
[TBL] [Abstract][Full Text] [Related]
15. [Cystatin C and cardiovascular risk].
Taglieri N; Koenig W; Kaski JC
Ann Biol Clin (Paris); 2010; 68(5):517-29. PubMed ID: 20870574
[TBL] [Abstract][Full Text] [Related]
16. Glomerular filtration rate, albuminuria, and risk of cardiovascular and all-cause mortality in the US population.
Astor BC; Hallan SI; Miller ER; Yeung E; Coresh J
Am J Epidemiol; 2008 May; 167(10):1226-34. PubMed ID: 18385206
[TBL] [Abstract][Full Text] [Related]
17. The values of estimated glomerular filtration rate calculated with creatinine and cystatin C based equations in healthy adults.
Dajak M; Ignjatović S; Jovicić S; Majkić-Singh N
Clin Lab; 2008; 54(5-6):153-9. PubMed ID: 18780660
[TBL] [Abstract][Full Text] [Related]
18. Cystatin C and incident peripheral arterial disease events in the elderly: results from the Cardiovascular Health Study.
O'Hare AM; Newman AB; Katz R; Fried LF; Stehman-Breen CO; Seliger SL; Siscovick DS; Shlipak MG
Arch Intern Med; 2005 Dec 12-26; 165(22):2666-70. PubMed ID: 16344426
[TBL] [Abstract][Full Text] [Related]
19. Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study.
Ix JH; Shlipak MG; Chertow GM; Whooley MA
Circulation; 2007 Jan; 115(2):173-9. PubMed ID: 17190862
[TBL] [Abstract][Full Text] [Related]
20. Serum cystatin C is associated with other cardiovascular risk markers and cardiovascular disease in elderly men.
Larsson A; Helmersson J; Hansson LO; Basu S
Int J Cardiol; 2008 Apr; 125(2):263-4. PubMed ID: 17996317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
